Boston Scientific Corporation
BSX
Clasificación en acciones
#409
Esta descripción de la empresa solo está disponible en inglés.
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
Precio por acción
$41.88
Última sincronización: 2026-10-30
Capitalización bursátil
$60.69B
Cambio (1 día)
-1.89%
Cambio (1 año)
-58.42%
País
US
Datos de acciones: Financial Modeling Prep·Actualizado el ·No es asesoramiento de inversión·Cómo lo calculamos
Comercio Boston Scientific Corporation (BSX)
Categoría
Healthcare
Margen Operativo de Boston Scientific Corporation (BSX)
Margen Operativo al November 2026 TTM: 21.05%
Según los informes financieros más recientes y el precio de las acciones de Boston Scientific Corporation, el margen operativo actual (TTM) es 21.05%. Al final de 2025, el margen operativo era 19.78%.
Historial de Margen Operativo de Boston Scientific Corporation desde 2000 hasta 2026
Margen Operativo al final de cada año
| Año | Margen Operativo | Variación |
|---|---|---|
| 2026 (TTM) | 21.05% | 6.42% |
| 2025 | 19.78% | 25.75% |
| 2024 | 15.73% | 2.68% |
| 2023 | 15.32% | 6.54% |
| 2022 | 14.38% | -11.07% |
| 2021 | 16.17% | 166.83% |
| 2020 | 6.06% | -62.01% |
| 2019 | 15.95% | -9.79% |
| 2018 | 17.68% | 4.93% |
| 2017 | 16.85% | 14.31% |
| 2016 | 14.74% | 39.45% |
| 2015 | 10.57% | -7.69% |
| 2014 | 11.45% | -6.07% |
| 2013 | 12.19% | -11.09% |
| 2012 | 13.71% | -6.92% |
| 2011 | 14.73% | 7.13% |
| 2010 | 13.75% | -13.58% |
| 2009 | 15.91% | -1.12% |
| 2008 | 16.09% | 13.95% |
| 2007 | 14.12% | -10.58% |
| 2006 | 15.79% | -50.98% |
| 2005 | 32.21% | 2.29% |
| 2004 | 31.49% | 57.06% |
| 2003 | 20.05% | -4.07% |
| 2002 | 20.90% | 458.82% |
| 2001 | 3.74% | -85.24% |
| 2000 | 25.34% | 0.00% |
Margen Operativo de empresas similares o competidoras
| Empresa | Margen Operativo | Diferencia de Margen Operativo | País |
|---|---|---|---|
| 15.24% | -99.28% |
US
|
|
| 18.08% | -99.14% |
IE
|
|
| 21.25% | -98.99% |
US
|
|
| 14.84% | -99.30% |
DE
|
|
| 28.09% | -98.67% |
US
|
¿Qué es el Margen Operativo de una empresa?
El Margen Operativo es un indicador clave para evaluar la rentabilidad de una empresa. Un margen operativo más alto suele ser mejor, ya que indica que una empresa puede vender sus productos o servicios por mucho más de lo que cuestan producirlos. Se calcula dividiendo las ganancias de la empresa entre sus ingresos.
Preguntas sobre el margen operativo de Boston Scientific Corporation
¿Cuál es el margen operativo de Boston Scientific Corporation?
Según los últimos datos (nov. 2026), el margen operativo de Boston Scientific Corporation es de 21.05%.
¿Cuál fue el margen operativo de Boston Scientific Corporation en 2025?
En 2025, el margen operativo de Boston Scientific Corporation fue de 19.78%, frente a 15.73% en 2024.
¿Cómo ha evolucionado el margen operativo de Boston Scientific Corporation desde 2020?
De 2020 a 2025, el margen operativo de Boston Scientific Corporation alcanzó su máximo en 2025 (19.78%) y su mínimo en 2020 (6.06%).
¿Cómo se sitúa el margen operativo de Boston Scientific Corporation frente a empresas similares?
Con 21.05%, el margen operativo de Boston Scientific Corporation supera el valor de 3 de las 5 empresas similares que aparecen arriba. Entre ellas, el valor más alto es el de Edwards Lifesciences Corporation (28.09%).